Enroll in HERConnection

HERConnection is a free support program from Genentech that provides information and resources to help educate and empower people living with HER2+ breast cancer. This program is designed specifically for individuals who have been prescribed PERJETA and Herceptin® (trastuzumab)‑based treatment. You’re invited to sign up and may receive important information about your treatment, including:

  • An informational treatment brochure
  • An email series based on where you are in your treatment
  • A notebook to keep track of your appointments and treatment notes
  • A cookbook full of recipes, tips, and caregiver ideas

Materials and information may differ depending on your course of treatment.

Personal Information (*indicates a required field)

Your personal information is only being collected so we can provide you with relevant information and resources based on your treatment journey. Please see below for additional details on Genentech’s Privacy Policy at the bottom of the page.

  • Alaska
  • Alabama
  • Arkansas
  • American Samoa
  • Arizona
  • California
  • Colorado
  • Connecticut
  • District Of Columbia
  • Delaware
  • Florida
  • Georgia
  • Guam
  • Hawaii
  • Iowa
  • Idaho
  • Illinois
  • Indiana
  • Kansas
  • Kentucky
  • Louisiana
  • Massachusetts
  • Maryland
  • Maine
  • Marshall Islands
  • Michigan
  • Minnesota
  • Missouri
  • Mississippi
  • Montana
  • North Carolina
  • North Dakota
  • Nebraska
  • New Hampshire
  • New Jersey
  • New Mexico
  • Nevada
  • New York
  • Ohio
  • Oklahoma
  • Oregon
  • Pennsylvania
  • Puerto Rico
  • Palau
  • Rhode Island
  • South Carolina
  • South Dakota
  • Tennessee
  • Texas
  • Utah
  • Virginia
  • Virgin Islands
  • Vermont
  • Washington
  • Wisconsin
  • West Virginia
  • Wyoming
  1. Early stage breast cancer. The cancer is in one or both breasts and may be in the lymph nodes under the arm.
  2. Metastatic breast cancer. The cancer has spread to other parts of the body, outside the breast and lymph nodes under the arm.

Remember, your doctor and your healthcare team should be your primary source of information. Only they can give you medical advice about your disease and treatment. Genentech’s intent is to provide information only to patients and caregivers in the United States or its territories.

By providing your information, you agree to allow Genentech and its agents to collect the information provided and to be contacted by Genentech and its agents in the future regarding PERJETA, other Genentech Products and related disease education. Furthermore, you are agreeing that Genentech and its agents may contact you by phone, email, or mail, and that such electronic or other written communications may include information regarding your health within them. Genentech will not sell, rent, or otherwise distribute your name and any personally identifiable information outside of Genentech and its agents. Genentech will only use your information in accordance with the Genentech Privacy Policy.

If you have any questions about the Genentech Privacy Policy or the information practices of our sites, you may contact us by e-mail at privacy.office@gene.com or by mail at:

Genentech, Inc.
Attn: Privacy Office
1 DNA Way
South San Francisco, CA 94080

You’re all set

Thank you for enrolling in HERConnection

We’re ready to help you through this treatment journey you have begun. We are going to provide knowledge, encouragement, and support materials to help keep you informed during this challenging time and help you celebrate the victories.

We look forward to connecting with you

In fact, you can check your email right now for a welcome message from HERConnection.

But before you go, remember, your doctor and your healthcare team should be your primary source of information. Only they can give you medical advice about your disease and treatment.